These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2209618)
1. The complete amino-acid sequences of human ganglioside GM2 activator protein and cerebroside sulfate activator protein. Fürst W; Schubert J; Machleidt W; Meyer HE; Sandhoff K Eur J Biochem; 1990 Sep; 192(3):709-14. PubMed ID: 2209618 [TBL] [Abstract][Full Text] [Related]
2. Interaction of GM2 activator protein with glycosphingolipids. Hama Y; Li YT; Li SC J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924 [TBL] [Abstract][Full Text] [Related]
3. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein. Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system. Schwarzmann G; Wendeler M; Sandhoff K Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415 [TBL] [Abstract][Full Text] [Related]
5. Substrate binding properties of the human liver hexosaminidase A activator protein. Hechtman P; Isaacs C; Smith-Jones L Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135 [TBL] [Abstract][Full Text] [Related]
6. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney]. Aronovich EL; Akhunov VS; Krasnopol'skaia KD Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574 [TBL] [Abstract][Full Text] [Related]
8. Porcine cerebroside sulfate activator: further structural characterization and disulfide identification. Stevens RL; Faull KF; Conklin KA; Green BN; Fluharty AL Biochemistry; 1993 Apr; 32(15):4051-9. PubMed ID: 8471613 [TBL] [Abstract][Full Text] [Related]
9. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis. Erzberger A; Conzelmann E; Sandhoff K Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795 [TBL] [Abstract][Full Text] [Related]
10. Expression and specificity of human GM2 activator protein. Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933 [TBL] [Abstract][Full Text] [Related]
11. N-terminal amino-acid sequence of a sphingolipid activator protein missing in a new human Gaucher disease variant. Christomanou H; Kleinschmidt T; Braunitzer G Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1193-6. PubMed ID: 3675870 [TBL] [Abstract][Full Text] [Related]
12. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875 [TBL] [Abstract][Full Text] [Related]
13. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Conzelmann E; Burg J; Stephan G; Sandhoff K Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531 [TBL] [Abstract][Full Text] [Related]
14. Cloning and sequence analysis of a cDNA clone coding for the mouse GM2 activator protein. Bellachioma G; Stirling JL; Orlacchio A; Beccari T Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):227-30. PubMed ID: 7689829 [TBL] [Abstract][Full Text] [Related]
15. Disulfide connectivity in cerebroside sulfate activator is not necessary for biological activity or alpha-helical content but is necessary for trypsin resistance and strong ligand binding. Faull KF; Higginson J; Waring AJ; Johnson J; To T; Whitelegge JP; Stevens RL; Fluharty CB; Fluharty AL Arch Biochem Biophys; 2000 Apr; 376(2):266-74. PubMed ID: 10775412 [TBL] [Abstract][Full Text] [Related]
17. A protein activator for the enzymic hydrolysis of GM2 ganglioside. Li SC; Hirabayashi Y; Li YT J Biol Chem; 1981 Jun; 256(12):6234-40. PubMed ID: 7240201 [No Abstract] [Full Text] [Related]
18. Preparation of the cerebroside sulfate activator (CSAct or saposin B) from human urine. Fluharty AL; Lombardo C; Louis A; Stevens RL; Whitelegge J; Waring AJ; To T; Fluharty CB; Faull KF Mol Genet Metab; 1999 Nov; 68(3):391-403. PubMed ID: 10562467 [TBL] [Abstract][Full Text] [Related]
19. Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation. Wendeler M; Hoernschemeyer J; Hoffmann D; Kolter T; Schwarzmann G; Sandhoff K Eur J Biochem; 2004 Feb; 271(3):614-27. PubMed ID: 14728689 [TBL] [Abstract][Full Text] [Related]
20. The precursor of sulfatide activator protein is processed to three different proteins. Fürst W; Machleidt W; Sandhoff K Biol Chem Hoppe Seyler; 1988 May; 369(5):317-28. PubMed ID: 3048308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]